Drug Type Therapeutic vaccine |
Synonyms Vaccinia virus double-deleted human interleukin 2(Allegheny-Singer Research Institute) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Esophageal Carcinoma | Phase 1 | United States | 06 May 2025 | |
Liver Cancer | Phase 1 | United States | 06 May 2025 | |
Liver metastases | Phase 1 | United States | 06 May 2025 | |
Microsatellite Stable Colorectal Carcinoma | Phase 1 | United States | 06 May 2025 | |
Secondary malignant neoplasm of peritoneum | Phase 1 | United States | 06 May 2025 | |
Spinocerebellar Degenerations | Phase 1 | United States | 06 May 2025 | |
stomach adenocarcinoma | Phase 1 | United States | 06 May 2025 |